» Articles » PMID: 20635434

MicroRNAs in Human Embryonic and Cancer Stem Cells

Overview
Journal Yonsei Med J
Specialty General Medicine
Date 2010 Jul 17
PMID 20635434
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that regulate messenger RNAs at the post-transcriptional level. They play an important role in the control of cell physiological functions, and their alterations have been related to cancer, where they can function as oncogenes or tumor suppressor genes. Recently, they have emerged as key regulators of "stemness", collaborating in the maintenance of pluripotency, control of self-renewal, and differentiation of stem cells. The miRNA pathway has been shown to be crucial in embryonic development and in embryonic stem (ES) cells, as shown by Dicer knockout analysis. Specific patterns of miRNAs have been reported to be expressed only in ES cells and in early phases of embryonic development. Moreover, many cancers present small populations of cells with stem cell characteristics, called cancer stem cells (CSCs). CSCs are responsible for relapse and treatment failure in many cancer patients, and the comparative analysis of expression patterns between ES cells and tumors can lead to the identification of a miRNA signature to define CSCs. Most of the key miRNAs identified to date in ES cells have been shown to play a role in tumor diagnosis or prognosis, and may well prove to be essential in cancer therapy in the foreseeable future.

Citing Articles

Discovering genes and microRNAs involved in human lung development unveils IGFBP3/miR-34a dynamics and their relevance for alveolar differentiation.

Acosta-Plasencia M, Castellano J, Diaz T, He Y, Marrades R, Navarro A Stem Cell Res Ther. 2024; 15(1):263.

PMID: 39183355 PMC: 11346212. DOI: 10.1186/s13287-024-03883-1.


Identification of Novel Lung Cancer Driver Genes Connecting Different Omics Levels With a Heat Diffusion Algorithm.

Yuan F, Cao X, Zhang Y, Chen L, Huang T, Li Z Front Cell Dev Biol. 2022; 10:825272.

PMID: 35155435 PMC: 8826452. DOI: 10.3389/fcell.2022.825272.


MicroRNAs and Stem-like Properties: The Complex Regulation Underlying Stemness Maintenance and Cancer Development.

Divisato G, Piscitelli S, Elia M, Cascone E, Parisi S Biomolecules. 2021; 11(8).

PMID: 34439740 PMC: 8393604. DOI: 10.3390/biom11081074.


Targeting Akt-associated microRNAs for cancer therapeutics.

Adil M, Khulood D, Somanath P Biochem Pharmacol. 2020; 189:114384.

PMID: 33347867 PMC: 8187261. DOI: 10.1016/j.bcp.2020.114384.


Hierarchical structural component modeling of microRNA-mRNA integration analysis.

Kim Y, Lee S, Choi S, Jang J, Park T BMC Bioinformatics. 2018; 19(Suppl 4):75.

PMID: 29745843 PMC: 5998903. DOI: 10.1186/s12859-018-2070-0.


References
1.
Gallardo E, Navarro A, Vinolas N, Marrades R, Diaz T, Gel B . miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Carcinogenesis. 2009; 30(11):1903-9. DOI: 10.1093/carcin/bgp219. View

2.
Aravin A, Lagos-Quintana M, Yalcin A, Zavolan M, Marks D, Snyder B . The small RNA profile during Drosophila melanogaster development. Dev Cell. 2003; 5(2):337-50. DOI: 10.1016/s1534-5807(03)00228-4. View

3.
Lin S, Chang D, Chang-Lin S, Lin C, Wu D, Chen D . Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA. 2008; 14(10):2115-24. PMC: 2553732. DOI: 10.1261/rna.1162708. View

4.
Morel A, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A . Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One. 2008; 3(8):e2888. PMC: 2492808. DOI: 10.1371/journal.pone.0002888. View

5.
Lakshmipathy U, Love B, Goff L, Jornsten R, Graichen R, Hart R . MicroRNA expression pattern of undifferentiated and differentiated human embryonic stem cells. Stem Cells Dev. 2007; 16(6):1003-16. PMC: 2743486. DOI: 10.1089/scd.2007.0026. View